Lunai Bioworks Announces Receipt of Nasdaq Determination and Intention to Voluntarily Delist and Deregister
Nasdaq's Listing Qualifications Department determined to delist Lunai Bioworks after the company failed the $2.5 million minimum stockholders' equity rule, reporting a $9.02 million stockholders' deficit in its fiscal 2026 10-K. Trading on Nasdaq is expected to be suspended at the open on October 30, 2026; the Board approved voluntary withdrawal on October 22 and will not request a hearing.
Key figures
- Form25 filing date
- on or about November 2, 2026
- Delisting effective
- on or about November 12, 2026
- Trading suspension date
- October 30, 2026
- Minimum equity requirement
- 2500000
AI analysis
Red flags5 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.